Labelling, counselling improvements

As part of its commitment to the safe and quality use of medicines, the PSA recently convened meetings to discuss improvements in the labelling and counselling for antibiotics and opioids by pharmacists Attended by medical, government, pharmacy and consumer stakeholders, and chaired by Emeritus Professor Lloyd Sansom AO, the meetings focused on reviewing cautionary advisory